| M2 polarization of murine peritoneal macrophages induces regulatory cytokine production and suppresses T‐cell proliferation S Oishi, R Takano, S Tamura, S Tani, M Iwaizumi, Y Hamaya, K Takagaki, ... Immunology 149 (3), 320-328, 2016 | 103 | 2016 |
| Highly bioavailable curcumin derivative ameliorates Crohn’s disease symptoms: A randomized, double-blind, multicenter study K Sugimoto, K Ikeya, S Bamba, A Andoh, H Yamasaki, K Mitsuyama, ... Journal of Crohn's and Colitis 14 (12), 1693-1701, 2020 | 49 | 2020 |
| A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis T Yamamoto, T Iida, K Ikeya, M Kato, A Matsuura, S Tamura, R Takano, ... Clinical and translational gastroenterology 9 (7), e170, 2018 | 25 | 2018 |
| Factors associated with healing of artificial ulcer after endoscopic submucosal dissection with reference to Helicobacter pylori infection, CYP2C19 genotype, and … Y Yoshizawa, M Sugimoto, Y Sato, S Sahara, H Ichikawa, T Kagami, ... Digestive Endoscopy 28 (2), 162-172, 2016 | 25 | 2016 |
| C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis N Ishida, T Higuchi, T Miyazu, S Tamura, S Tani, M Yamade, M Iwaizumi, ... Scientific Reports 11 (1), 12431, 2021 | 20 | 2021 |
| Digoxin attenuates murine experimental colitis by downregulating Th17-related cytokines S Tani, R Takano, S Tamura, S Oishi, M Iwaizumi, Y Hamaya, K Takagaki, ... Inflammatory Bowel Diseases 23 (5), 728-738, 2017 | 17 | 2017 |
| Evaluating mucosal healing using colon capsule endoscopy predicts outcome in patients with ulcerative colitis in clinical remission R Takano, S Osawa, T Uotani, S Tani, N Ishida, S Tamura, M Yamade, ... World journal of clinical cases 6 (15), 952, 2018 | 15 | 2018 |
| Photodynamic therapy using talaporfin sodium for local failure after chemoradiotherapy or radiotherapy for esophageal cancer: a single center experience N Ishida, S Osawa, T Miyazu, M Kaneko, S Tamura, S Tani, M Yamade, ... Journal of Clinical Medicine 9 (5), 1509, 2020 | 14 | 2020 |
| Real-world efficacy and safety monitoring for predicting continuation of tofacitinib therapy in patients with ulcerative colitis N Ishida, T Miyazu, S Tamura, S Tani, M Yamade, M Iwaizumi, Y Hamaya, ... Digestive Diseases and Sciences 67 (8), 3984-3992, 2022 | 11 | 2022 |
| Prostaglandin E-major urinary metabolite versus fecal immunochemical occult blood test as a biomarker for patient with ulcerative colitis N Ishida, T Miyazu, R Takano, S Tamura, S Tani, T Kagami, M Yamade, ... BMC gastroenterology 20, 1-10, 2020 | 11 | 2020 |
| Effect of ulcerative colitis duration on the usefulness of immunochemical fecal occult blood test result as a disease activity biomarker N Ishida, T Miyazu, T Matsuura, R Takano, S Tamura, T Kagami, S Tani, ... International Journal of Colorectal Disease 35, 1729-1739, 2020 | 11 | 2020 |
| Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome N Ishida, T Miyazu, S Tamura, S Tani, M Yamade, M Iwaizumi, Y Hamaya, ... World Journal of Gastroenterology 27 (22), 3109, 2021 | 9 | 2021 |
| Further research on the clinical relevance of the ulcerative colitis colonoscopic index of severity for predicting 5-year relapse N Ishida, S Onoue, T Miyazu, S Tamura, S Tani, M Yamade, M Iwaizumi, ... International Journal of Colorectal Disease 36, 2661-2670, 2021 | 8 | 2021 |
| Prostaglandin E-major urinary metabolite predicts relapse in patients with ulcerative colitis in clinical remission N Ishida, K Sugiura, T Miyazu, S Tamura, S Suzuki, S Tani, M Yamade, ... Clinical and translational gastroenterology 11 (12), e00289, 2020 | 8 | 2020 |
| Therapeutic monitoring of adalimumab at non-trough levels in patients with inflammatory bowel disease M Kato, K Sugimoto, K Ikeya, R Takano, A Matsuura, T Miyazu, N Ishida, ... Plos one 16 (7), e0254548, 2021 | 7 | 2021 |
| Mesalazine granule formulation improves clinical data in Crohn's disease compared with tablet formulation S Tamura, N Ishida, T Miyazu, S Onoue, S Tani, M Yamade, Y Hamaya, ... Scientific Reports 10 (1), 21353, 2020 | 7 | 2020 |
| Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey H Nakase, K Wagatsuma, M Nojima, T Matsumoto, M Matsuura, H Iijima, ... Journal of Gastroenterology 58 (3), 205-216, 2023 | 6 | 2023 |
| Assessment of long-term efficacy and safety of adalimumab in patients with ulcerative colitis: results from a 6-year real-world clinical practice K Sugimoto, K Ikeya, M Kato, A Matsuura, F Watanabe, R Takano, ... Digestive Diseases 37 (1), 11-20, 2018 | 6 | 2018 |
| Ambient scanning tunneling microscopy and atomic force microscopy on GaAs (110) treated with (NH4)2Sx and SeS2 solutions S Nozaki, S Tamura, K Takahashi Journal of Vacuum Science & Technology B: Microelectronics and Nanometer …, 1995 | 6 | 1995 |
| Lymphocyte to monocyte ratio and serum albumin changes predict tacrolimus therapy outcomes in patients with ulcerative colitis N Ishida, S Tani, Y Asai, T Miyazu, S Tamura, M Yamade, M Iwaizumi, ... Scientific Reports 12 (1), 13572, 2022 | 5 | 2022 |
Ken SugimotoFirst Department of Medicine, Hamamatsu University School of MedicineVerified email at hama-med.ac.jp
